Cargando…

Statement on the risk assessment of maximum residue levels (MRLs) for oxamyl in view of consumer protection

In accordance with Article 43 of Regulation (EC) No 396/2005, the European Commission requested EFSA to perform a risk assessment of the existing maximum residues levels (MRLs) for oxamyl considering the new toxicological reference values. Additionally, if needed to ensure adequate consumer protecti...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977561/
https://www.ncbi.nlm.nih.gov/pubmed/36875866
http://dx.doi.org/10.2903/j.efsa.2023.7823
_version_ 1784899319454760960
collection PubMed
description In accordance with Article 43 of Regulation (EC) No 396/2005, the European Commission requested EFSA to perform a risk assessment of the existing maximum residues levels (MRLs) for oxamyl considering the new toxicological reference values. Additionally, if needed to ensure adequate consumer protection, lower limits of quantification (LOQs) than those currently established in the legislation should be proposed. EFSA performed various consumer exposure calculation scenarios, considering the risk assessment values as available for the existing uses of oxamyl and the lowering of LOQs for several plant and animal commodities as suggested by the European Union Reference Laboratories for Pesticide Residues (EURLs). Based on the results of the consumer exposure assessment calculated considering the risk assessment values for crops with authorised oxamyl uses and the existing EU MRLs at the LOQ for remaining commodities (scenario 1), chronic consumer intake concerns were identified for 34 diets. Acute exposure concerns were identified for a wide range of crops, including crops with currently authorised oxamyl uses: bananas, potatoes, melons, cucumbers, carrots, watermelons, tomatoes, courgettes, parsnips, salsifies and aubergines/eggplants. Under exposure calculation scenario 3, which considered lowering of all MRLs to the lowest analytically achievable limits of quantification, EFSA concludes that chronic consumer exposure concerns can still not be excluded. Similarly, acute consumer exposure concerns were identified for 16 commodities, including crops with known authorised uses: potatoes, melons, watermelons and tomatoes, even though for these crops a lower LOQ as proposed by the EURLs were considered. Further refinements of the calculated exposure at the current stage were not possible by EFSA, but EFSA identified a list of commodities for which a lower LOQ than routinely achievable is expected to significantly reduce the consumer exposure and for which a risk management decision is required.
format Online
Article
Text
id pubmed-9977561
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99775612023-03-02 Statement on the risk assessment of maximum residue levels (MRLs) for oxamyl in view of consumer protection EFSA J Reasoned Opinion In accordance with Article 43 of Regulation (EC) No 396/2005, the European Commission requested EFSA to perform a risk assessment of the existing maximum residues levels (MRLs) for oxamyl considering the new toxicological reference values. Additionally, if needed to ensure adequate consumer protection, lower limits of quantification (LOQs) than those currently established in the legislation should be proposed. EFSA performed various consumer exposure calculation scenarios, considering the risk assessment values as available for the existing uses of oxamyl and the lowering of LOQs for several plant and animal commodities as suggested by the European Union Reference Laboratories for Pesticide Residues (EURLs). Based on the results of the consumer exposure assessment calculated considering the risk assessment values for crops with authorised oxamyl uses and the existing EU MRLs at the LOQ for remaining commodities (scenario 1), chronic consumer intake concerns were identified for 34 diets. Acute exposure concerns were identified for a wide range of crops, including crops with currently authorised oxamyl uses: bananas, potatoes, melons, cucumbers, carrots, watermelons, tomatoes, courgettes, parsnips, salsifies and aubergines/eggplants. Under exposure calculation scenario 3, which considered lowering of all MRLs to the lowest analytically achievable limits of quantification, EFSA concludes that chronic consumer exposure concerns can still not be excluded. Similarly, acute consumer exposure concerns were identified for 16 commodities, including crops with known authorised uses: potatoes, melons, watermelons and tomatoes, even though for these crops a lower LOQ as proposed by the EURLs were considered. Further refinements of the calculated exposure at the current stage were not possible by EFSA, but EFSA identified a list of commodities for which a lower LOQ than routinely achievable is expected to significantly reduce the consumer exposure and for which a risk management decision is required. John Wiley and Sons Inc. 2023-03-01 /pmc/articles/PMC9977561/ /pubmed/36875866 http://dx.doi.org/10.2903/j.efsa.2023.7823 Text en © 2023 European Food Safety Authority. EFSA Journal published by Wiley‐VCH GmbH on behalf of European Food Safety Authority. https://creativecommons.org/licenses/by-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ (https://creativecommons.org/licenses/by-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made.
spellingShingle Reasoned Opinion
Statement on the risk assessment of maximum residue levels (MRLs) for oxamyl in view of consumer protection
title Statement on the risk assessment of maximum residue levels (MRLs) for oxamyl in view of consumer protection
title_full Statement on the risk assessment of maximum residue levels (MRLs) for oxamyl in view of consumer protection
title_fullStr Statement on the risk assessment of maximum residue levels (MRLs) for oxamyl in view of consumer protection
title_full_unstemmed Statement on the risk assessment of maximum residue levels (MRLs) for oxamyl in view of consumer protection
title_short Statement on the risk assessment of maximum residue levels (MRLs) for oxamyl in view of consumer protection
title_sort statement on the risk assessment of maximum residue levels (mrls) for oxamyl in view of consumer protection
topic Reasoned Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977561/
https://www.ncbi.nlm.nih.gov/pubmed/36875866
http://dx.doi.org/10.2903/j.efsa.2023.7823
work_keys_str_mv AT statementontheriskassessmentofmaximumresiduelevelsmrlsforoxamylinviewofconsumerprotection